Praxis Precision Medicines (PRAX) Non Operating Income (2019 - 2026)

Praxis Precision Medicines' Non Operating Income history runs 8 years deep, the most recent figure standing at $13.3 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 144.83% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $30.8 million (up 50.63% YoY), while the FY2025 annual figure was $22.9 million, up 32.19% from the prior year.
• Non Operating Income was $13.3 million for Q1 2026 at Praxis Precision Medicines, up from $8.1 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $13.3 million in Q1 2026 to a low of $132000.0 in Q1 2022.
• Historically, Non Operating Income has averaged $3.4 million across 5 years, with a median of $2.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Non Operating Income surged 642.44% in 2024, then declined 10.15% in 2025.
• A 5-year view of Non Operating Income shows it stood at $280000.0 in 2022, then soared by 231.43% to $928000.0 in 2023, then surged by 468.64% to $5.3 million in 2024, then surged by 54.12% to $8.1 million in 2025, then jumped by 63.52% to $13.3 million in 2026.
• The last three Non Operating Income figures came in at $13.3 million (Q1 2026), $8.1 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.